Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:42 PM
Ignite Modification Date:
2025-12-26 @ 2:42 PM
NCT ID:
NCT03249506
Eligibility Criteria:
Inclusion Criteria:
* Type 2 diabetes mellitus (T2DM), defined as: greater than or equal to (\>=) 1 anti-hyperglycemic agent (AHA) medication in the study period, and; \>=1 diagnosis of T2DM in any available diagnosis field on or prior to index
* Established cardiovascular disease, defined as \>=1 diagnosis in any diagnosis field for any of the following conditions: cerebrovascular disease; coronary artery disease (including heart failure \[HF\]); peripheral artery disease
* \>=1-year pre-index continuous eligibility; enrollment gaps of less than or equal to (\<=) 30 days will be considered continuous enrollment
Exclusion Criteria:
* Type 1 Diabetes mellitus (T1DM) diagnosis on or prior to the index date
* Secondary diabetes mellitus (DM) on or prior to the index date
* Missing sex data
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03249506
Study Brief:
Protocol Section:
NCT03249506